Citations

Showing 10 of 108094 citations.

Micro-fragmented adipose tissue for treatment of knee osteoarthritis with Baker’s cyst: a case study
Arthurs, Jennifer R. , Desmond, Cheryl M, TerKonda, Sarvam P. , Desmond, Cheryl M., Shapiro, Shane A.

Mayo Clinic

BMJ Case Reports | June 4, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-224426

10.1136/bcr-2018-224426 | PMID 29866683 Get It

Adipose-derived therapies have increased in popularity for treatment of painful orthopaedic conditions, such as osteoarthritis. We report the passage of fat into a Baker’s cyst after injection of micro-fragmented adipose tissue in a patient with bilateral knee arthritis. Following fat grafting, the patient required drainage of fatty fluid from within the Baker’s cyst on multiple occasions. Approximately 3 months postprocedure, she began to notice an improvement in her knee pain with no further recurrence of pain or swelling from her Baker’s cyst.
Effects of Brain-Derived Neurotrophic Factor on MicroRNA Expression Profile in Human Endothelial Progenitor Cells
He, Tongrong , Sun, Ruohan , Katušić, Zvonimir S. , Li, Ying

Mayo Clinic

Cell Transplantation | June 4, 2018 | Volume: 27 | Issue: 6 | Pages: 1005-1009

10.1177/0963689718761658 | PMID 29860902 Get It

The mechanisms underlying proangiogenic function of brain-derived neurotrophic factor (BDNF) are not fully understood. The current study was designed to explore the microRNA (miRNA) profile in human early endothelial progenitor cells (EPCs, also referred to as CFU-Hill cells) treated with BDNF. Treatment of early EPCs with BDNF for 7 d significantly increased the colony formation of outgrowth endothelial cells. BDNF suppressed the expression of miR-4716-5p, miR-3928, miR-433, miR-1294, miR-1539, and miR-19b-1*. In contrast, BDNF significantly increased the levels of miR-432*, miR-4499, miR-3911, miR-1183, miR-4669, miR-636, miR-4717-3p, miR-4298, miR485-5p, and miR-181c. Since miR-433 has been reported to augment hematopoietic cells proliferation and differentiation, we examined the role of miR-433 in regenerative effects of BDNF. BDNF stimulated the protein expression of guanylate-binding protein 2 via the suppression of miR-433. However, the knockdown of miR-433 was not sufficient to significantly increase the number of outgrowth endothelial cell colonies, suggesting that modulation of miR-433 alone does not stimulate regenerative capacity of EPCs. In aggregate, our results also suggest that the effect of BDNF on regenerative function of EPCs may depend on complex changes in the expression of microRNAs.
Tracheal chondrosarcoma and surgical management
Khan, Fazal Wahab , Zahid, Ibrahim , Moeen, Sarosh, Hasan, Sulaiman Bashir

Mayo Clinic

Asian Cardiovascular and Thoracic Annals | June 4, 2018 | Volume: 27 | Issue: 1 | Pages: 52-54

10.1177/0218492318778484 | PMID 29860896 Get It

Chondrosarcoma is a cancer of cartilage cells, and despite being a common primary bone tumor, tracheal chondrosarcoma is rare with only 18 cases reported in the literature prior to mid-2016. A 60-year-old gentleman presented with progressively increasing cough, severe stridor, and production of phlegm for approximately 2 years. On admission to our tertiary care hospital, he developed complete obstructive apnea within an hour, and was intubated. A tracheal biopsy was performed, followed by resection. Histopathology confirmed chondrosarcoma of the trachea. The patient tolerated the procedure very well and is currently symptom-free on follow-up, with no signs of recurrence.
Pre- and post-pericardiocentesis echo-Doppler features of effusive-constrictive pericarditis compared with cardiac tamponade and constrictive pericarditis
Miranda, William R. , Newman, Darrell B. , Sinak, Lawrence J., Espinosa, Raúl E. , Anavekar, Nandan S., Oh, Jae K., Goel, Kashish , Oh, Jae K.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | June 3, 2018 | Volume: 20 | Issue: 3 | Pages: 298-306

10.1093/ehjci/jey081 | PMID 29982372 Get It

Potential impact of introducing a nonavalent HPV vaccination
Taverna, Francesca , Lombardo, Claudia , Signorelli, Mauro , Casarin, Jvan , Scaffa, Cono , Maggiore, Umberto Leone Roberti , Recalcati, Dario , Ditto, Antonino , Martinelli, Fabio , Borghi, Chiara , Perotto, Stefania , Ferrero, Simone , Lorusso, Domenica , Raspagliesi, Francesco , Leone Roberti Maggiore, Umberto , Bogani, Giorgio , Chiappa, Valentina

Mayo Clinic

International Journal of Gynecology & Obstetrics | June 2, 2018 | Volume: 142 | Issue: 3 | Pages: 338-342

10.1002/ijgo.12546 | PMID 29858884 Get It

AbstractObjectiveTo test the theoretical utility of incorporating nonavalent vaccination against HPV into a clinical setting.MethodsThe present retrospective study included data from consecutive patients who underwent HPV‐DNA testing between January 1, 1998, and December 31, 2015. Changes in the prevalence of different HPV types were assessed during three periods (T1, 1998–2003; T2, 2004–2009; and T3, 2010–2015) using XY analysis.ResultsThe study included a total of 13 665 patients. Overall, 1361, 5130, and 7174 patients were included in the T1, T2, and T3 periods, respectively. The quadrivalent vaccine would have potentially protected against HPV in 71.5% (973/1361), 46.5% (2385/5130), and 26.5% (1901/7174) of patients in T1, T2, and T3, respectively (P<0.001 for trend). The nonavalent vaccine could have protected against HPV in 92.5% (1259/1361), 72.3% (3709/5130), and 58.1% (4168/7174) of patients in T1, T2, and T3, respectively (P<0.001 for trend). The proportion of patients with genital dysplasia grade 2+ who did not have infections with HPV genotypes covered by the quadrivalent or nonavalent vaccines increased across the three periods (P<0.001 for trend). For all study periods, the protection provided by the nonavalent vaccine would have been superior to the quadrivalent vaccine (χ2 test P<0.001).ConclusionThe introduction of a nonavalent vaccine could improve protection against HPV infections and HPV‐related genital dysplasia.
Fragmentation of QRS complex during ventricular pacing is associated with ventricular arrhythmic events in patients with left ventricular dysfunction
Munoz, Freddy Del‐Carpio , Gharacholou, S. Michael , Cha, Yong‐Mei , Munger, Thomas M. , Friedman, Paul A. , Asirvatham, Samuel J. , Del-Carpio Munoz, Freddy , Cha, Yong-Mei , Friedman, Paul A , Asirvatham, Samuel J , Noseworthy, Peter A. , Scott, Christopher G. , Nkomo, Vuyisile T. , López-Jiménez, Francisco

Mayo Clinic

Journal of Cardiovascular Electrophysiology | June 2, 2018 | Volume: 29 | Issue: 9 | Pages: 1248-1256

10.1111/jce.13656 | PMID 29858880 Get It

AbstractBackgroundQRS fragmentation (fQRS) during baseline ventricular conduction, a myocardial fibrosis marker, is associated with increased risk of ventricular tachyarrhythmias but may not manifest unless ventricular activation change is provoked. We examined the association of fQRS during right ventricular (RV) pacing with death and ventricular tachyarrhythmia in patients with left ventricular (LV) dysfunction undergoing electrophysiology study (EPS).Methods and resultsStudy participants had LV dysfunction (ejection fraction < 50%) undergoing EPS from January 2002 to May 2014 at Mayo Clinic in Rochester, Minnesota. fQRS during RV stimulation involved >2 notches on R/S waves identified in ≥2 contiguous standard electrocardiographic leads representing anterior, inferior, or lateral ventricular segments. Primary outcomes were ventricular tachyarrhythmias that were symptomatic or required intervention and total and cardiac deaths. In all, 528 patients participated (mean age, 65 years; male sex, 80%). Of them, 312 (59%) had ischemic cardiomyopathy and mean (SD) left ventricular ejection fraction (LVEF) of 33.2% (9.5%); 457 (87%) had implantable cardiac devices (implanted defibrillator, n = 380). Mean (SD) follow‐up was 3.2 (3.0) years. fQRS during RV pacing was observed in 292 patients (60%) in any ventricular segment. Patients with fQRS during RV pacing had 2.5 higher rate of ventricular tachyarrhythmia events than patients with no fQRS (hazard ratio [95% CI], 2.45 [1.5–4.2]; P < 0.01), after correcting for baseline ventricular conduction defect and QRS duration, LVEF, inducible sustained ventricular tachycardia, diabetes mellitus, chronic kidney disease, and ischemic cardiomyopathy.ConclusionsRV stimulation can unmask fQRS, and it is associated with increased risk of ventricular tachyarrhythmia in LV dysfunction.
Outcomes of video‐assisted thoracoscopic surgery for transvenous lead extraction
Dai, Mingyan , Joyce, David L. , Friedman, Paul A. , Espinosa, Raúl E. , Osborn, Michael J., Huang, Congxin , Cha, Yong‐Mei , Blackmon, Shanda, Friedman, Paul A , Espinosa, Raul, Cha, Yong-Mei , Blackmon, Shanda

Mayo Clinic

Journal of Cardiovascular Electrophysiology | June 2, 2018 | Volume: 29 | Issue: 7 | Pages: 1032-1037

10.1111/jce.13643 | PMID 29858883 Get It

AbstractIntroductionTo evaluate the outcomes of video‐assisted thoracoscopic surgery (VATS) during transvenous lead extractions (TLEs).Methods and resultsNinety‐one high‐risk patients who underwent TLE in the operating room from January 1, 2015, to March 31, 2017, were included in the study. Of these, 9 patients underwent VATS during TLE. Their clinical characteristics, indications for lead extraction, and complications associated with TLE in the 9 patients who had VATS were compared with those for the 82 patients who did not have VATS. The mean (SD) age of the study patients was 61 (17) years (64.8% were male). The lead dwell time, number of leads extracted, and clinical comorbidities were similar between the 2 groups. Superior vena cava (SVC) tear occurred in 2 of the 9 patients in VATS group and in 1 of the 82 in the non‐VATS group (22.2% vs. 1.2%, P = 0.03). Of the 2 patients in the VATS group who had SVC tears, in 1 the tear was visualized immediately and there was no hemodynamic compromise. In the other patient, the SVC tear was within the pericardium; the blood pressure recovered quickly after sternotomy and repair. Both patients had complete lead extraction and survived hospitalization. The patient in the non‐VATS group who had an SVC tear had a successful repair but died of postoperative complications.ConclusionsUtilization of VATS to facilitate TLE is beneficial for early recognition of SVC tear and timely surgical repair in select high‐risk patients.
Association between delayed gastric emptying and upper gastrointestinal symptoms: a systematic review and meta-analysis
Vijayvargiya, Priya , Jameie‐Oskooei, Sina, Camilleri, Michael , Chedid, Victor , Erwin, Patricia J., Murad, M. Hassan , Murad, Mohammad Hassan, Murad, M Hassan , Chedid, Victor G

Mayo Clinic

Gut | June 2, 2018 | Volume: 68 | Issue: 5 | Pages: 804-813

10.1136/gutjnl-2018-316405 | PMID 29860241 Get It

Background The relationship between delayed gastric emptying and upper GI symptoms (UGI Sx) is controversial. Objective To assess association between gastric emptying and UGI Sx, independent of treatment. Design We performed a systematic review and meta-analysis of the literature from 2007 to 2017, review of references and additional papers identified by content expert. We included studies evaluating the association between gastric emptying and nausea, vomiting, early satiety/postprandial fullness, abdominal pain and bloating. Covariate analyses included optimal gastric emptying test method, gastric emptying type (breath test or scintigraphy) and patient category. Meta-regression compared the differences based on type of gastric emptying tests. Results Systematic review included 92 gastric emptying studies (26 breath test, 62 scintigraphy, 1 ultrasound and 3 wireless motility capsule); 25 of these studies provided quantitative data for meta-analysis (15 scintigraphy studies enrolling 4056 participants and 10 breath test studies enrolling 2231 participants). Meta-regression demonstrated a significant difference between optimal and suboptimal gastric emptying test methods when comparing delayed gastric emptying with nausea and vomiting. On evaluating studies using optimal gastric emptying test methodology, there were significant associations between gastric emptying and nausea (OR 1.6, 95% CI 1.4 to 1.8), vomiting (OR 2.0, 95% CI 1.6 to 2.7), abdominal pain (OR 1.5, 95% CI 1.0 to 2.2 ) and early satiety/fullness (OR 1.8, 95% CI 1.2 to 2.6) for patients with UGI Sx; gastric emptying and early satiety/fullness in patients with diabetes; gastric emptying and nausea in patients with gastroparesis. Conclusions The systematic review and meta-analysis supports an association between optimally measured delayed gastric emptying and UGI Sx.
Dorsal Failures: From Saddle Deformity to Pollybeak
Hamilton, Grant

Mayo Clinic

Facial Plastic Surgery | June 1, 2018 | Volume: 34 | Issue: 03 | Pages: 261-269

10.1055/s-0038-1653990 | PMID 29857336 Get It

AbstractThe nasal dorsum is an important component of a rhinoplasty and may be the primary motivation for seeking surgery. The nasal dorsum is a complex three-dimensional shape that is shrouded by local anesthetic and edema during surgery. This makes an accurate assessment of the surgical changes challenging. Complications related to dorsal modification include imbalances from over- or underresection of the structures of the nasal dorsum, inadequate or overaugmentation, an open-roof deformity, pollybeak, saddle nose, inverted-V, warped cartilage, visible grafts, contour problems, graft malposition, and extrusion. This review will discuss the common problems that can occur with dorsal modification during rhinoplasty.
Medical Therapy As Compared To Surgical Device Exchange for Left Ventricular Assist Device Thrombosis: A Systematic Review and Meta-Analysis
Luc, Jessica G.Y. , Tchantchaleishvili, Vakhtang , Maltais, Simon, Stulak, John M., Dunlay, Shannon M. , Tchantchaleishvili, Vakhtang , Phan, Kevin H.

Mayo Clinic

ASAIO Journal | June 1, 2018 | Volume: 65 | Issue: 4 | Pages: 307-317

10.1097/mat.0000000000000833 | PMID 29863631 Get It

Pump thrombosis is a major adverse event in patients supported on continuous-flow left ventricular assist devices (CF-LVAD). The aim of this systematic review and meta-analysis was to determine the outcomes of various treatment approaches for pump thrombosis, including surgical as compared to medical therapy. Electronic search was performed to identify all studies in the English literature addressing surgical and medical management of pump thrombosis in the modern CF-LVAD era. All identified articles were systematically assessed for inclusion and exclusion criteria. In the meta-analysis, because of significant overlap of the data, reports based on trials, registries, and individual cohort studies were analyzed separately. Forty-three studies were included in the analysis (2 trials, 4 registry reports, and 37 individual cohort studies). 2,281/28,728 (10.6%) patients developed pump thrombosis, of which 44.4% and 55.1% were supported on the HeartWare and HeartMate II, respectively. To avoid overlap in studies and to seek more granular data, pooled individual cohort studies were found to be representative of the entire population, and further in-depth analysis of this category was performed. Of the 610/5,545 (11.8%) patients with pump thrombosis in these individual cohort studies, 225 patients had surgical pump exchange, and 186 were treated medically. Surgical therapy resulted in higher success as compared to medical therapy (81.3% vs. 45.4%; p < 0.001), lower 30 day mortality rate (16.7% vs. 34.5%; p = 0.013) and recurrence rate (11.8% vs. 38.3%; p < 0.001). Meta-regression of all studies demonstrates a possible temporal increase of pump thrombosis rate (p = 0.040). Surgical pump exchange is superior to medical therapy with a higher success rate of pump thrombosis resolution, lower mortality rate, and lower recurrence rate. Randomized controlled prospective studies are needed to compare these clinical approaches and their resultant outcomes to guide decision-making for the management of CF-LVAD thrombosis.